Wojciech Rogowski
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A case of high-grade prostate cancer with low PSA levels.
Journal: Urology case reports
Published: July 05, 2025
Remarks on Selected Morphological Aspects of Cancer Neuroscience: A Microscopic Photo Review.
Journal: Biomedicines
Published: August 22, 2024
Initial Experience of Clinical Use of [99mTc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 10, 2021
Investigation of Neural Microenvironment in Prostate Cancer in Context of Neural Density, Perineural Invasion, and Neuroendocrine Profile of Tumors.
Journal: Frontiers in oncology
Published: May 17, 2021
Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland.
Journal: Polish archives of internal medicine
Published: May 19, 2020
Capecitabine and temozolomide combination for treatment of high-grade, well-differentiated neuroendocrine tumour and poorly-differentiated neuroendocrine carcinoma - retrospective analysis.
Journal: Endokrynologia Polska
Published: February 14, 2019
Interleukin-33 polymorphisms and serum concentrations in mycosis fungoides.
Journal: International journal of dermatology
Published: November 14, 2018
Successful treatment of an enterovesical fistula due to Crohn's disease with stem cell transplantation: a case report.
Journal: Przeglad gastroenterologiczny
Published: October 08, 2018
Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
Journal: BioMed research international
Published: November 19, 2017
Baseline chromogranin A and its dynamics are prognostic markers in gastroenteropancreatic neuroendocrine tumors.
Journal: Future oncology (London, England)
Published: January 18, 2017
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study.
Journal: The Lancet. Oncology
Published: August 04, 2016
Last Updated: 09/26/2026